Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 2026 FDA Peptide Reclassification Purefico Medspa and Therapy BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning Orthopedic Use of BPC 157 Sports Med Review